Navigation Links
Terascala Closes Additional Funding Based on Strong OEM Sales and Release of ISB

Boston, MA (PRWEB) November 05, 2013

Terascala, the fast data company, today announced the closing of additional funding from existing venture capitalists and several new investors. Ascent Venture Partners, Harborlight Capital Partners, and Thomas Weisel Partners co-led the equity investment. In addition, the company also signed a significant financing package with Bridge Bank, N.A. of San Jose, Calif. Under the terms of the financing package, Terascala secured two lines of working capital as well as an additional asset based lending facility. Details of the funding were not made public.

Over the last few months, Terascala has transitioned the company to a pure original equipment manufacturer (OEM) sales model and as a result, has been able to reorganize the company in such a manner to better support the needs of their primary OEM partners. OEM sales, primarily thru Dell and NetApp grew by over 100 percent in 2012 and are expected to finish 2013 with annual growth exceeding 75 percent. The business has grown significantly in the higher education, energy, and genomics markets, where the company’s partners have strong solutions and a significant presence.

The funding round will enable additional investments in Terascala’s latest product, the Intelligent Storage Bridge (ISB). Released in Q3, the ISB has already resulted in several orders and provides Terascala’s OEMs the potential to market integrated high-performance computing (HPC) and network-attached storage (NAS) solutions, an industry first. The ISB is a high-performance workflow manager designed to transfer large data sets quickly and automatically between fast scratch storage and enterprise storage.

Terascala’s products can be seen in the Dell booth #1301 and NetApp booth #601 at SC13 on November 17-22, 2013 at the Colorado Convention Center, Denver, Colorado.

“I am excited to announce the additional funding and the continued support of our investor syndicate. They are seeing the OEM sales growth and also hearing from enterprise customers that TeraOS-powered storage platforms in combination with ISB help establish the most efficient HPC infrastructure. Users are empowered with an easy to use, highly scalable, and highly reliable file system, rich analytics to optimize performance, and a high performance workflow with direct access to their project data at any point in the workflow," said Steve Butler, CEO for Terascala.

“Terascala is making great strides in its OEM business model, and we are excited about the company’s future. We were particularly pleased to see the growth and initial sales of the ISB with Dell, NetApp and other channel partners; we believe that the company will continue to grow at a rapid rate and are pleased to be an investor in the company,” added Walter Dick, Managing Partner, Ascent Venture Partners.

About Terascala

Terascala is the fast data company. Terascala storage appliances dramatically accelerate the time to insight for organizations that rely on simulation, analysis, and modeling tools to bring new products and innovation to market. Exclusively available through strategic partners Dell and NetApp, Terascala storage appliances provide on-demand throughput at multiple gigabytes per second while leveraging industry-leading storage platforms for long-term data protection. Learn more at

Connect with Terascala
Read our blog:
Follow us on Twitter:
Watch a video:

Terascala and the Terascala logo are trademarks of Terascala, Inc. All other brands, products, or service names may be trademarks or property of their respective holders.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Terascala Special Report Features Gartner Research to Help R&D and IT Users Accelerate Performance with HPC Storage Appliances
2. The University of North Texas Installs Terascala in Its New High-Performance Computing Cluster
3. Terascala Advances Its Vision of Optimizing High-Performance Computing Workflows for Faster Time to Results
4. Radius Closes $27.65 Million Second Tranche of Previously Announced Financing
5. Avaxia Biologics, Inc. Closes $4.1 Million Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
6. OncoSec Closes $7.75 Million Public Offering
7. AyoxxA Biosystems Closes Series A Financing Round
8. Enviva Closes on $120 Million Senior Secured Credit Facility
9. Avelas Biosciences Closes $7.65 Million Series A, Advances Real-Time Tumor Visualization Technology Toward Development
10. Biscayne Pharmaceuticals Closes $1.5 Million Financing To Advance Recent Discoveries Of Pioneering Endocrine Drug Researcher
11. Nasseo, Inc. Joins BioInspire™ Medical Technology Incubator, Closes Seed Funding Round
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 Studies ... and human plaque and pave the way for more effective ... in cats     --> ... commonly diagnosed health problems in cats, yet relatively little was ... Two collaborative studies have been conducted by researchers from the ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... of Black Aerospace Professionals (OPBAP) has been formalized with the signing of a ... leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn Tuesday, ...
(Date:11/24/2015)... Nov. 24, 2015  Asia-Pacific (APAC) holds the ... (CRO) market. The trend of outsourcing to low-cost ... but higher volume share for the region in ... however, margins in the CRO industry will improve. ... ( ), finds that the market ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ... today reported financial results for the quarter ended ... expressed in Canadian dollars and presented under International ... United States ," said Andrew Rae ... advancements regarding iCo-008 are not only value enriching ...
Breaking Biology Technology:
(Date:11/10/2015)... 2015 About signature verification ... to identify and verify the identity of an ... the secure and accurate method of authentication and ... individual because each individual,s signature is highly unique. ... dynamic signature of an individual is compared and ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
Breaking Biology News(10 mins):